Stylage
Commercial- Indications
- Aesthetic medicine
Company intelligence / Profile preview
Laboratoires Vivacy’s products are CE-marked and widely used by healthcare professionals globally. Their hyaluronic acid-based injectables have demonstrated safety and efficacy across aesthetic medicine, gynaecology, rheumatology, and ophthalmology. The company’s STYLAGE® line leads in facial aesthetics; DESIRIAL® was the first CE-marked injectable for women’s intimate health; KARTILAGE® addresses osteoarthritis pain; I.SPACE® supports ophthalmic procedures[1][4].
Clinical results are supported by numerous studies showing high patient satisfaction rates and low adverse event profiles.
The company operates under strict EU medical device regulations with a modern GMP-compliant facility[1].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoires Vivacy.